Company | Biogen
Company | Biogen
Nov 2, 2020
biogen.com
Biogen Inc.: Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments
Biogen Inc.: Biogen and Stoke Therapeutics Enter into Collaborat…
Feb 18, 2025
finanznachrichten.de
Biogen Inc.: LEQEMBI IQLIK(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's Best Inventions of 2025
Biogen Inc.: LEQEMBI IQLIK(lecanemab-irmb) Subcutane…
4 months ago
finanznachrichten.de
We believe that no other disease area holds as much need or promise for breakthroughs as neuroscience. Through technology, research and our commitment to individuals living with complex diseases, we know we can make great strides within the field, together. #NeuroPioneers | Biogen
0:43
We believe that no other disease area holds as much need or promi…
8.7K viewsDec 7, 2018
FacebookBiogen
13 reactions | 45 years ago, Biogen began with the mission to provide...
0:08
13 reactions | 45 years ago, Biogen began with the mission to provide...
2K views1 week ago
FacebookBiogen
Biogen shares soar on landmark Alzheimer's data, lift rivals
1:58
Biogen shares soar on landmark Alzheimer's data, lift rivals
Sep 28, 2022
ReutersNatalie Grover,Manas Mishra
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to …
8 months ago
marketscreener.com
Biogen Inc.: Biogen and Stoke Therapeutics Announce Presentat…
8 months ago
finanznachrichten.de
1:02
133 reactions · 67 shares | Today marks a historic day in Biogen’s c…
5.2K views1 month ago
FacebookBiogen
Clinical Trials | Biogen
Nov 15, 2022
biogen.com
1:12
First patient receives controversial Biogen Alzheimer’s drug
Jun 17, 2021
ReutersDeena Beasley
0:10
3.1K views | Meet Nick Wilson. An immunology pioneer in research …
77.3K views2 weeks ago
FacebookBiogen
0:47
Biogen Alzheimer's drug closer to approval with U.S. FDA staff backi…
Nov 5, 2020
ReutersDeena Beasley,Manojna Maddipatla
Biogen Gets U.S., European Reviews of Higher-Dose Spinraza
Jan 23, 2025
marketscreener.com
1:51
FDA approves first Alzheimer’s drug in nearly 20 years despite controv…
Jun 7, 2021
newsnationnow.com
Biogen Inc.: Biogen and Stoke Therapeutics Announce Presentat…
6 months ago
finanznachrichten.de
Biogen Inc.: LEQEMBI (Lecanemab) Approved for the Treatment of Alz…
5 months ago
finanznachrichten.de
0:22
As 2024 wraps up, we’re reflecting on all that we’ve accomplished an…
322 viewsDec 30, 2024
FacebookBiogen
2:32
We are pioneers in neuroscience. We are Biogen.
2.6K viewsNov 26, 2019
YouTubeBiogen
In dramatic turn, Biogen seeks FDA approval for experimental Alzheim…
Oct 22, 2019
goodmorningamerica.com
Biogen CEO Sees New Chapter in Fight Against Alzheimer's
Jun 8, 2021
Bloomberg.comJohn Tozzi
0:25
Biogen seeks FDA approval for experimental Alzheimer's drug
Oct 22, 2019
ABC NewsErin Schumaker
Biogen Inc. : Wedbush est neutre
4 months ago
zonebourse.com
1:59
645K views · 706 reactions | Shares of Biogen soared more than 40% a…
645.4K views3 weeks ago
FacebookReuters
Biogen Inc.: LEQEMBI (lecanemab) IV Maintenance Dosing for the Tre…
4 months ago
finanznachrichten.de
Biogen Inc.: Biogen and Stoke Therapeutics Present Data at the 3…
Feb 9, 2025
finanznachrichten.de
1:32
U.S. approval of Biogen Alzheimer's drug sends shares soaring, haile…
Jun 7, 2021
ReutersJulie Steenhuysen,Deena Beasley
Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 – Here’s …
3 weeks ago
YahooNoor Ul Ain Rehman
Biogen Inc.: Leqembi? (lecanemab) is the First Medicine that Slows Pr…
10 months ago
finanznachrichten.de
See more videos
Static thumbnail place holder